nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ORM1—Vandetanib—thyroid cancer	0.245	0.338	CbGbCtD
Nortriptyline—ALB—Vandetanib—thyroid cancer	0.103	0.142	CbGbCtD
Nortriptyline—HTR2C—Sorafenib—thyroid cancer	0.102	0.141	CbGbCtD
Nortriptyline—CYP3A5—Sorafenib—thyroid cancer	0.05	0.069	CbGbCtD
Nortriptyline—CYP2C19—Sorafenib—thyroid cancer	0.0403	0.0556	CbGbCtD
Nortriptyline—CYP1A2—Sorafenib—thyroid cancer	0.0372	0.0513	CbGbCtD
Nortriptyline—CYP2C9—Sorafenib—thyroid cancer	0.0335	0.0463	CbGbCtD
Nortriptyline—CYP3A4—Vandetanib—thyroid cancer	0.0324	0.0446	CbGbCtD
Nortriptyline—CYP2D6—Sorafenib—thyroid cancer	0.0307	0.0423	CbGbCtD
Nortriptyline—CYP3A4—Sorafenib—thyroid cancer	0.0195	0.0269	CbGbCtD
Nortriptyline—CYP2D6—Doxorubicin—thyroid cancer	0.0186	0.0257	CbGbCtD
Nortriptyline—Conduction disorder—Vandetanib—thyroid cancer	0.0157	0.0855	CcSEcCtD
Nortriptyline—Electrocardiogram QT corrected interval prolonged—Vandetanib—thyroid cancer	0.0122	0.0666	CcSEcCtD
Nortriptyline—CYP3A4—Doxorubicin—thyroid cancer	0.0118	0.0163	CbGbCtD
Nortriptyline—Electrocardiogram QT prolonged—Vandetanib—thyroid cancer	0.00513	0.0279	CcSEcCtD
Nortriptyline—Torsade de pointes—Vandetanib—thyroid cancer	0.0047	0.0256	CcSEcCtD
Nortriptyline—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.00305	0.0166	CcSEcCtD
Nortriptyline—Gynaecomastia—Sorafenib—thyroid cancer	0.00199	0.0108	CcSEcCtD
Nortriptyline—Pollakiuria—Vandetanib—thyroid cancer	0.00191	0.0104	CcSEcCtD
Nortriptyline—Weight decreased—Vandetanib—thyroid cancer	0.00187	0.0102	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00185	0.01	CcSEcCtD
Nortriptyline—Stomatitis—Vandetanib—thyroid cancer	0.0018	0.00977	CcSEcCtD
Nortriptyline—Bundle branch block—Epirubicin—thyroid cancer	0.00163	0.00886	CcSEcCtD
Nortriptyline—Eye disorder—Vandetanib—thyroid cancer	0.00155	0.00841	CcSEcCtD
Nortriptyline—Bundle branch block—Doxorubicin—thyroid cancer	0.00151	0.00819	CcSEcCtD
Nortriptyline—Arrhythmia—Vandetanib—thyroid cancer	0.00148	0.00804	CcSEcCtD
Nortriptyline—Alopecia—Vandetanib—thyroid cancer	0.00146	0.00795	CcSEcCtD
Nortriptyline—Dysgeusia—Vandetanib—thyroid cancer	0.00141	0.00767	CcSEcCtD
Nortriptyline—Vision blurred—Vandetanib—thyroid cancer	0.00136	0.00738	CcSEcCtD
Nortriptyline—Tremor—Vandetanib—thyroid cancer	0.00135	0.00734	CcSEcCtD
Nortriptyline—Erectile dysfunction—Sorafenib—thyroid cancer	0.00128	0.00699	CcSEcCtD
Nortriptyline—Loss of consciousness—Vandetanib—thyroid cancer	0.00127	0.00689	CcSEcCtD
Nortriptyline—Weight decreased—Sorafenib—thyroid cancer	0.00126	0.00686	CcSEcCtD
Nortriptyline—Convulsion—Vandetanib—thyroid cancer	0.00125	0.00679	CcSEcCtD
Nortriptyline—Hypertension—Vandetanib—thyroid cancer	0.00124	0.00677	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00123	0.00667	CcSEcCtD
Nortriptyline—Anxiety—Vandetanib—thyroid cancer	0.00122	0.00665	CcSEcCtD
Nortriptyline—Myocardial infarction—Sorafenib—thyroid cancer	0.00122	0.00663	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00122	0.00663	CcSEcCtD
Nortriptyline—Bone marrow depression—Epirubicin—thyroid cancer	0.00122	0.00662	CcSEcCtD
Nortriptyline—Stomatitis—Sorafenib—thyroid cancer	0.00121	0.00659	CcSEcCtD
Nortriptyline—Jaundice—Sorafenib—thyroid cancer	0.00121	0.00659	CcSEcCtD
Nortriptyline—Dry mouth—Vandetanib—thyroid cancer	0.0012	0.00652	CcSEcCtD
Nortriptyline—Oedema—Vandetanib—thyroid cancer	0.00117	0.0064	CcSEcCtD
Nortriptyline—Thrombocytopenia—Vandetanib—thyroid cancer	0.00115	0.00626	CcSEcCtD
Nortriptyline—Bone marrow depression—Doxorubicin—thyroid cancer	0.00113	0.00613	CcSEcCtD
Nortriptyline—Dermatitis atopic—Epirubicin—thyroid cancer	0.00111	0.00604	CcSEcCtD
Nortriptyline—Insomnia—Vandetanib—thyroid cancer	0.00106	0.00578	CcSEcCtD
Nortriptyline—Paraesthesia—Vandetanib—thyroid cancer	0.00106	0.00574	CcSEcCtD
Nortriptyline—Gingivitis—Epirubicin—thyroid cancer	0.00105	0.00569	CcSEcCtD
Nortriptyline—Tinnitus—Sorafenib—thyroid cancer	0.00104	0.00566	CcSEcCtD
Nortriptyline—Flushing—Sorafenib—thyroid cancer	0.00104	0.00564	CcSEcCtD
Nortriptyline—Dyspepsia—Vandetanib—thyroid cancer	0.00103	0.00563	CcSEcCtD
Nortriptyline—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00103	0.00559	CcSEcCtD
Nortriptyline—Decreased appetite—Vandetanib—thyroid cancer	0.00102	0.00556	CcSEcCtD
Nortriptyline—Fatigue—Vandetanib—thyroid cancer	0.00101	0.00551	CcSEcCtD
Nortriptyline—Constipation—Vandetanib—thyroid cancer	0.001	0.00547	CcSEcCtD
Nortriptyline—Petechiae—Epirubicin—thyroid cancer	0.000998	0.00543	CcSEcCtD
Nortriptyline—Arrhythmia—Sorafenib—thyroid cancer	0.000997	0.00542	CcSEcCtD
Nortriptyline—Alopecia—Sorafenib—thyroid cancer	0.000986	0.00537	CcSEcCtD
Nortriptyline—Gingivitis—Doxorubicin—thyroid cancer	0.000968	0.00527	CcSEcCtD
Nortriptyline—Delirium—Epirubicin—thyroid cancer	0.000955	0.0052	CcSEcCtD
Nortriptyline—Dysgeusia—Sorafenib—thyroid cancer	0.000951	0.00518	CcSEcCtD
Nortriptyline—Body temperature increased—Vandetanib—thyroid cancer	0.000929	0.00506	CcSEcCtD
Nortriptyline—Abdominal pain—Vandetanib—thyroid cancer	0.000929	0.00506	CcSEcCtD
Nortriptyline—Petechiae—Doxorubicin—thyroid cancer	0.000923	0.00503	CcSEcCtD
Nortriptyline—Nocturia—Epirubicin—thyroid cancer	0.000885	0.00482	CcSEcCtD
Nortriptyline—Delirium—Doxorubicin—thyroid cancer	0.000883	0.00481	CcSEcCtD
Nortriptyline—Syncope—Sorafenib—thyroid cancer	0.000871	0.00474	CcSEcCtD
Nortriptyline—Leukopenia—Sorafenib—thyroid cancer	0.000869	0.00473	CcSEcCtD
Nortriptyline—Loss of consciousness—Sorafenib—thyroid cancer	0.000854	0.00465	CcSEcCtD
Nortriptyline—Atrioventricular block—Epirubicin—thyroid cancer	0.000846	0.00461	CcSEcCtD
Nortriptyline—Asthenia—Vandetanib—thyroid cancer	0.000843	0.00459	CcSEcCtD
Nortriptyline—Hypertension—Sorafenib—thyroid cancer	0.000838	0.00456	CcSEcCtD
Nortriptyline—Coordination abnormal—Epirubicin—thyroid cancer	0.000836	0.00455	CcSEcCtD
Nortriptyline—Pruritus—Vandetanib—thyroid cancer	0.000831	0.00452	CcSEcCtD
Nortriptyline—Ventricular tachycardia—Epirubicin—thyroid cancer	0.000821	0.00447	CcSEcCtD
Nortriptyline—Nocturia—Doxorubicin—thyroid cancer	0.000819	0.00446	CcSEcCtD
Nortriptyline—Dry mouth—Sorafenib—thyroid cancer	0.000809	0.0044	CcSEcCtD
Nortriptyline—Diarrhoea—Vandetanib—thyroid cancer	0.000804	0.00438	CcSEcCtD
Nortriptyline—Atrioventricular block—Doxorubicin—thyroid cancer	0.000783	0.00426	CcSEcCtD
Nortriptyline—Shock—Sorafenib—thyroid cancer	0.00078	0.00424	CcSEcCtD
Nortriptyline—Dizziness—Vandetanib—thyroid cancer	0.000777	0.00423	CcSEcCtD
Nortriptyline—Thrombocytopenia—Sorafenib—thyroid cancer	0.000776	0.00422	CcSEcCtD
Nortriptyline—Coordination abnormal—Doxorubicin—thyroid cancer	0.000774	0.00421	CcSEcCtD
Nortriptyline—Aplastic anaemia—Epirubicin—thyroid cancer	0.000771	0.0042	CcSEcCtD
Nortriptyline—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00076	0.00414	CcSEcCtD
Nortriptyline—Anorexia—Sorafenib—thyroid cancer	0.000756	0.00411	CcSEcCtD
Nortriptyline—Vomiting—Vandetanib—thyroid cancer	0.000747	0.00407	CcSEcCtD
Nortriptyline—Rash—Vandetanib—thyroid cancer	0.000741	0.00403	CcSEcCtD
Nortriptyline—Dermatitis—Vandetanib—thyroid cancer	0.00074	0.00403	CcSEcCtD
Nortriptyline—Headache—Vandetanib—thyroid cancer	0.000736	0.00401	CcSEcCtD
Nortriptyline—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000713	0.00388	CcSEcCtD
Nortriptyline—Nausea—Vandetanib—thyroid cancer	0.000698	0.0038	CcSEcCtD
Nortriptyline—Dyspepsia—Sorafenib—thyroid cancer	0.000698	0.0038	CcSEcCtD
Nortriptyline—Decreased appetite—Sorafenib—thyroid cancer	0.000689	0.00375	CcSEcCtD
Nortriptyline—Fatigue—Sorafenib—thyroid cancer	0.000683	0.00372	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000682	0.00371	CcSEcCtD
Nortriptyline—Constipation—Sorafenib—thyroid cancer	0.000678	0.00369	CcSEcCtD
Nortriptyline—Vascular purpura—Epirubicin—thyroid cancer	0.000666	0.00363	CcSEcCtD
Nortriptyline—Eye pain—Epirubicin—thyroid cancer	0.00066	0.00359	CcSEcCtD
Nortriptyline—Hot flush—Epirubicin—thyroid cancer	0.000637	0.00347	CcSEcCtD
Nortriptyline—Menopausal symptoms—Epirubicin—thyroid cancer	0.000632	0.00344	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000631	0.00343	CcSEcCtD
Nortriptyline—Urticaria—Sorafenib—thyroid cancer	0.00063	0.00343	CcSEcCtD
Nortriptyline—Abdominal pain—Sorafenib—thyroid cancer	0.000627	0.00341	CcSEcCtD
Nortriptyline—Body temperature increased—Sorafenib—thyroid cancer	0.000627	0.00341	CcSEcCtD
Nortriptyline—Purpura—Epirubicin—thyroid cancer	0.000618	0.00337	CcSEcCtD
Nortriptyline—Vascular purpura—Doxorubicin—thyroid cancer	0.000616	0.00336	CcSEcCtD
Nortriptyline—Eye pain—Doxorubicin—thyroid cancer	0.000611	0.00332	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000608	0.00331	CcSEcCtD
Nortriptyline—Hot flush—Doxorubicin—thyroid cancer	0.000589	0.00321	CcSEcCtD
Nortriptyline—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000584	0.00318	CcSEcCtD
Nortriptyline—Hypersensitivity—Sorafenib—thyroid cancer	0.000584	0.00318	CcSEcCtD
Nortriptyline—Purpura—Doxorubicin—thyroid cancer	0.000572	0.00311	CcSEcCtD
Nortriptyline—Asthenia—Sorafenib—thyroid cancer	0.000569	0.0031	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000563	0.00306	CcSEcCtD
Nortriptyline—Pruritus—Sorafenib—thyroid cancer	0.000561	0.00305	CcSEcCtD
Nortriptyline—Ataxia—Epirubicin—thyroid cancer	0.00056	0.00305	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000544	0.00296	CcSEcCtD
Nortriptyline—Diarrhoea—Sorafenib—thyroid cancer	0.000542	0.00295	CcSEcCtD
Nortriptyline—Dizziness—Sorafenib—thyroid cancer	0.000524	0.00285	CcSEcCtD
Nortriptyline—Ataxia—Doxorubicin—thyroid cancer	0.000519	0.00282	CcSEcCtD
Nortriptyline—Eosinophilia—Epirubicin—thyroid cancer	0.00051	0.00278	CcSEcCtD
Nortriptyline—Vomiting—Sorafenib—thyroid cancer	0.000504	0.00274	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000504	0.00274	CcSEcCtD
Nortriptyline—Rash—Sorafenib—thyroid cancer	0.0005	0.00272	CcSEcCtD
Nortriptyline—Dermatitis—Sorafenib—thyroid cancer	0.000499	0.00272	CcSEcCtD
Nortriptyline—Headache—Sorafenib—thyroid cancer	0.000497	0.0027	CcSEcCtD
Nortriptyline—Pancytopenia—Epirubicin—thyroid cancer	0.000489	0.00266	CcSEcCtD
Nortriptyline—Pollakiuria—Epirubicin—thyroid cancer	0.000476	0.00259	CcSEcCtD
Nortriptyline—Eosinophilia—Doxorubicin—thyroid cancer	0.000472	0.00257	CcSEcCtD
Nortriptyline—Nausea—Sorafenib—thyroid cancer	0.000471	0.00256	CcSEcCtD
Nortriptyline—Weight increased—Epirubicin—thyroid cancer	0.000469	0.00255	CcSEcCtD
Nortriptyline—Weight decreased—Epirubicin—thyroid cancer	0.000466	0.00254	CcSEcCtD
Nortriptyline—Drowsiness—Epirubicin—thyroid cancer	0.000459	0.0025	CcSEcCtD
Nortriptyline—Pancytopenia—Doxorubicin—thyroid cancer	0.000453	0.00246	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00045	0.00245	CcSEcCtD
Nortriptyline—Jaundice—Epirubicin—thyroid cancer	0.000448	0.00244	CcSEcCtD
Nortriptyline—Stomatitis—Epirubicin—thyroid cancer	0.000448	0.00244	CcSEcCtD
Nortriptyline—Sweating—Epirubicin—thyroid cancer	0.00044	0.0024	CcSEcCtD
Nortriptyline—Pollakiuria—Doxorubicin—thyroid cancer	0.00044	0.0024	CcSEcCtD
Nortriptyline—Weight increased—Doxorubicin—thyroid cancer	0.000434	0.00236	CcSEcCtD
Nortriptyline—Weight decreased—Doxorubicin—thyroid cancer	0.000431	0.00235	CcSEcCtD
Nortriptyline—Agranulocytosis—Epirubicin—thyroid cancer	0.000429	0.00233	CcSEcCtD
Nortriptyline—Drowsiness—Doxorubicin—thyroid cancer	0.000425	0.00231	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000417	0.00227	CcSEcCtD
Nortriptyline—Stomatitis—Doxorubicin—thyroid cancer	0.000414	0.00225	CcSEcCtD
Nortriptyline—Jaundice—Doxorubicin—thyroid cancer	0.000414	0.00225	CcSEcCtD
Nortriptyline—Hepatitis—Epirubicin—thyroid cancer	0.000412	0.00224	CcSEcCtD
Nortriptyline—Hypoaesthesia—Epirubicin—thyroid cancer	0.00041	0.00223	CcSEcCtD
Nortriptyline—Sweating—Doxorubicin—thyroid cancer	0.000407	0.00222	CcSEcCtD
Nortriptyline—Oedema peripheral—Epirubicin—thyroid cancer	0.000406	0.00221	CcSEcCtD
Nortriptyline—Agranulocytosis—Doxorubicin—thyroid cancer	0.000397	0.00216	CcSEcCtD
Nortriptyline—Eye disorder—Epirubicin—thyroid cancer	0.000385	0.0021	CcSEcCtD
Nortriptyline—Tinnitus—Epirubicin—thyroid cancer	0.000384	0.00209	CcSEcCtD
Nortriptyline—Flushing—Epirubicin—thyroid cancer	0.000383	0.00208	CcSEcCtD
Nortriptyline—Hepatitis—Doxorubicin—thyroid cancer	0.000381	0.00208	CcSEcCtD
Nortriptyline—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00038	0.00207	CcSEcCtD
Nortriptyline—Oedema peripheral—Doxorubicin—thyroid cancer	0.000376	0.00205	CcSEcCtD
Nortriptyline—Arrhythmia—Epirubicin—thyroid cancer	0.000368	0.002	CcSEcCtD
Nortriptyline—Alopecia—Epirubicin—thyroid cancer	0.000364	0.00198	CcSEcCtD
Nortriptyline—Eye disorder—Doxorubicin—thyroid cancer	0.000357	0.00194	CcSEcCtD
Nortriptyline—Tinnitus—Doxorubicin—thyroid cancer	0.000356	0.00194	CcSEcCtD
Nortriptyline—Flushing—Doxorubicin—thyroid cancer	0.000354	0.00193	CcSEcCtD
Nortriptyline—Tension—Epirubicin—thyroid cancer	0.000352	0.00192	CcSEcCtD
Nortriptyline—Dysgeusia—Epirubicin—thyroid cancer	0.000351	0.00191	CcSEcCtD
Nortriptyline—Nervousness—Epirubicin—thyroid cancer	0.000349	0.0019	CcSEcCtD
Nortriptyline—Arrhythmia—Doxorubicin—thyroid cancer	0.000341	0.00185	CcSEcCtD
Nortriptyline—Vision blurred—Epirubicin—thyroid cancer	0.000338	0.00184	CcSEcCtD
Nortriptyline—Alopecia—Doxorubicin—thyroid cancer	0.000337	0.00183	CcSEcCtD
Nortriptyline—Ill-defined disorder—Epirubicin—thyroid cancer	0.000333	0.00181	CcSEcCtD
Nortriptyline—Agitation—Epirubicin—thyroid cancer	0.00033	0.0018	CcSEcCtD
Nortriptyline—Tension—Doxorubicin—thyroid cancer	0.000326	0.00177	CcSEcCtD
Nortriptyline—Dysgeusia—Doxorubicin—thyroid cancer	0.000325	0.00177	CcSEcCtD
Nortriptyline—Malaise—Epirubicin—thyroid cancer	0.000324	0.00176	CcSEcCtD
Nortriptyline—Nervousness—Doxorubicin—thyroid cancer	0.000323	0.00176	CcSEcCtD
Nortriptyline—Syncope—Epirubicin—thyroid cancer	0.000322	0.00175	CcSEcCtD
Nortriptyline—Leukopenia—Epirubicin—thyroid cancer	0.000321	0.00175	CcSEcCtD
Nortriptyline—Palpitations—Epirubicin—thyroid cancer	0.000317	0.00173	CcSEcCtD
Nortriptyline—Loss of consciousness—Epirubicin—thyroid cancer	0.000315	0.00172	CcSEcCtD
Nortriptyline—Vision blurred—Doxorubicin—thyroid cancer	0.000313	0.0017	CcSEcCtD
Nortriptyline—Convulsion—Epirubicin—thyroid cancer	0.000311	0.00169	CcSEcCtD
Nortriptyline—Hypertension—Epirubicin—thyroid cancer	0.00031	0.00169	CcSEcCtD
Nortriptyline—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000308	0.00168	CcSEcCtD
Nortriptyline—Agitation—Doxorubicin—thyroid cancer	0.000305	0.00166	CcSEcCtD
Nortriptyline—Anxiety—Epirubicin—thyroid cancer	0.000305	0.00166	CcSEcCtD
Nortriptyline—Discomfort—Epirubicin—thyroid cancer	0.000302	0.00164	CcSEcCtD
Nortriptyline—Malaise—Doxorubicin—thyroid cancer	0.000299	0.00163	CcSEcCtD
Nortriptyline—Dry mouth—Epirubicin—thyroid cancer	0.000299	0.00163	CcSEcCtD
Nortriptyline—Syncope—Doxorubicin—thyroid cancer	0.000298	0.00162	CcSEcCtD
Nortriptyline—Leukopenia—Doxorubicin—thyroid cancer	0.000297	0.00162	CcSEcCtD
Nortriptyline—Confusional state—Epirubicin—thyroid cancer	0.000295	0.00161	CcSEcCtD
Nortriptyline—Palpitations—Doxorubicin—thyroid cancer	0.000293	0.0016	CcSEcCtD
Nortriptyline—Oedema—Epirubicin—thyroid cancer	0.000293	0.00159	CcSEcCtD
Nortriptyline—Loss of consciousness—Doxorubicin—thyroid cancer	0.000292	0.00159	CcSEcCtD
Nortriptyline—Shock—Epirubicin—thyroid cancer	0.000288	0.00157	CcSEcCtD
Nortriptyline—Convulsion—Doxorubicin—thyroid cancer	0.000288	0.00157	CcSEcCtD
Nortriptyline—Thrombocytopenia—Epirubicin—thyroid cancer	0.000287	0.00156	CcSEcCtD
Nortriptyline—Hypertension—Doxorubicin—thyroid cancer	0.000287	0.00156	CcSEcCtD
Nortriptyline—Tachycardia—Epirubicin—thyroid cancer	0.000286	0.00156	CcSEcCtD
Nortriptyline—Hyperhidrosis—Epirubicin—thyroid cancer	0.000283	0.00154	CcSEcCtD
Nortriptyline—Anxiety—Doxorubicin—thyroid cancer	0.000282	0.00153	CcSEcCtD
Nortriptyline—Discomfort—Doxorubicin—thyroid cancer	0.000279	0.00152	CcSEcCtD
Nortriptyline—Anorexia—Epirubicin—thyroid cancer	0.000279	0.00152	CcSEcCtD
Nortriptyline—Dry mouth—Doxorubicin—thyroid cancer	0.000277	0.00151	CcSEcCtD
Nortriptyline—Hypotension—Epirubicin—thyroid cancer	0.000274	0.00149	CcSEcCtD
Nortriptyline—Confusional state—Doxorubicin—thyroid cancer	0.000273	0.00149	CcSEcCtD
Nortriptyline—Oedema—Doxorubicin—thyroid cancer	0.000271	0.00148	CcSEcCtD
Nortriptyline—Shock—Doxorubicin—thyroid cancer	0.000267	0.00145	CcSEcCtD
Nortriptyline—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000265	0.00144	CcSEcCtD
Nortriptyline—Insomnia—Epirubicin—thyroid cancer	0.000265	0.00144	CcSEcCtD
Nortriptyline—Tachycardia—Doxorubicin—thyroid cancer	0.000265	0.00144	CcSEcCtD
Nortriptyline—Paraesthesia—Epirubicin—thyroid cancer	0.000263	0.00143	CcSEcCtD
Nortriptyline—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000262	0.00143	CcSEcCtD
Nortriptyline—Somnolence—Epirubicin—thyroid cancer	0.00026	0.00142	CcSEcCtD
Nortriptyline—Anorexia—Doxorubicin—thyroid cancer	0.000258	0.00141	CcSEcCtD
Nortriptyline—Dyspepsia—Epirubicin—thyroid cancer	0.000258	0.0014	CcSEcCtD
Nortriptyline—Decreased appetite—Epirubicin—thyroid cancer	0.000255	0.00139	CcSEcCtD
Nortriptyline—Hypotension—Doxorubicin—thyroid cancer	0.000253	0.00138	CcSEcCtD
Nortriptyline—Fatigue—Epirubicin—thyroid cancer	0.000253	0.00137	CcSEcCtD
Nortriptyline—Constipation—Epirubicin—thyroid cancer	0.00025	0.00136	CcSEcCtD
Nortriptyline—Insomnia—Doxorubicin—thyroid cancer	0.000245	0.00133	CcSEcCtD
Nortriptyline—Paraesthesia—Doxorubicin—thyroid cancer	0.000243	0.00132	CcSEcCtD
Nortriptyline—Feeling abnormal—Epirubicin—thyroid cancer	0.000241	0.00131	CcSEcCtD
Nortriptyline—Somnolence—Doxorubicin—thyroid cancer	0.000241	0.00131	CcSEcCtD
Nortriptyline—Dyspepsia—Doxorubicin—thyroid cancer	0.000239	0.0013	CcSEcCtD
Nortriptyline—Decreased appetite—Doxorubicin—thyroid cancer	0.000236	0.00128	CcSEcCtD
Nortriptyline—Fatigue—Doxorubicin—thyroid cancer	0.000234	0.00127	CcSEcCtD
Nortriptyline—Urticaria—Epirubicin—thyroid cancer	0.000233	0.00127	CcSEcCtD
Nortriptyline—Constipation—Doxorubicin—thyroid cancer	0.000232	0.00126	CcSEcCtD
Nortriptyline—Abdominal pain—Epirubicin—thyroid cancer	0.000232	0.00126	CcSEcCtD
Nortriptyline—Body temperature increased—Epirubicin—thyroid cancer	0.000232	0.00126	CcSEcCtD
Nortriptyline—Feeling abnormal—Doxorubicin—thyroid cancer	0.000223	0.00122	CcSEcCtD
Nortriptyline—Hypersensitivity—Epirubicin—thyroid cancer	0.000216	0.00117	CcSEcCtD
Nortriptyline—Urticaria—Doxorubicin—thyroid cancer	0.000215	0.00117	CcSEcCtD
Nortriptyline—Abdominal pain—Doxorubicin—thyroid cancer	0.000214	0.00117	CcSEcCtD
Nortriptyline—Body temperature increased—Doxorubicin—thyroid cancer	0.000214	0.00117	CcSEcCtD
Nortriptyline—Asthenia—Epirubicin—thyroid cancer	0.00021	0.00114	CcSEcCtD
Nortriptyline—Pruritus—Epirubicin—thyroid cancer	0.000207	0.00113	CcSEcCtD
Nortriptyline—Diarrhoea—Epirubicin—thyroid cancer	0.0002	0.00109	CcSEcCtD
Nortriptyline—Hypersensitivity—Doxorubicin—thyroid cancer	0.0002	0.00109	CcSEcCtD
Nortriptyline—Asthenia—Doxorubicin—thyroid cancer	0.000194	0.00106	CcSEcCtD
Nortriptyline—Dizziness—Epirubicin—thyroid cancer	0.000194	0.00105	CcSEcCtD
Nortriptyline—Pruritus—Doxorubicin—thyroid cancer	0.000192	0.00104	CcSEcCtD
Nortriptyline—Vomiting—Epirubicin—thyroid cancer	0.000186	0.00101	CcSEcCtD
Nortriptyline—Diarrhoea—Doxorubicin—thyroid cancer	0.000185	0.00101	CcSEcCtD
Nortriptyline—Rash—Epirubicin—thyroid cancer	0.000185	0.00101	CcSEcCtD
Nortriptyline—Dermatitis—Epirubicin—thyroid cancer	0.000185	0.001	CcSEcCtD
Nortriptyline—Headache—Epirubicin—thyroid cancer	0.000184	0.000999	CcSEcCtD
Nortriptyline—Dizziness—Doxorubicin—thyroid cancer	0.000179	0.000976	CcSEcCtD
Nortriptyline—Nausea—Epirubicin—thyroid cancer	0.000174	0.000947	CcSEcCtD
Nortriptyline—Vomiting—Doxorubicin—thyroid cancer	0.000172	0.000938	CcSEcCtD
Nortriptyline—Rash—Doxorubicin—thyroid cancer	0.000171	0.00093	CcSEcCtD
Nortriptyline—Dermatitis—Doxorubicin—thyroid cancer	0.000171	0.000929	CcSEcCtD
Nortriptyline—Headache—Doxorubicin—thyroid cancer	0.00017	0.000924	CcSEcCtD
Nortriptyline—Nausea—Doxorubicin—thyroid cancer	0.000161	0.000876	CcSEcCtD
Nortriptyline—CHRM4—head—thyroid cancer	0.000109	0.0593	CbGeAlD
Nortriptyline—CHRM1—saliva-secreting gland—thyroid cancer	9.84e-05	0.0535	CbGeAlD
Nortriptyline—HTR6—head—thyroid cancer	9.76e-05	0.0531	CbGeAlD
Nortriptyline—CHRM3—saliva-secreting gland—thyroid cancer	8.8e-05	0.0479	CbGeAlD
Nortriptyline—CHRM5—head—thyroid cancer	8.52e-05	0.0464	CbGeAlD
Nortriptyline—ADRA1B—head—thyroid cancer	7.79e-05	0.0424	CbGeAlD
Nortriptyline—ADRA1D—head—thyroid cancer	7.62e-05	0.0414	CbGeAlD
Nortriptyline—CHRM1—trachea—thyroid cancer	7.59e-05	0.0413	CbGeAlD
Nortriptyline—HTR2A—neck—thyroid cancer	6.7e-05	0.0364	CbGeAlD
Nortriptyline—CHRM2—head—thyroid cancer	5.85e-05	0.0318	CbGeAlD
Nortriptyline—HTR2C—head—thyroid cancer	5.64e-05	0.0307	CbGeAlD
Nortriptyline—CHRM3—thyroid gland—thyroid cancer	5.37e-05	0.0292	CbGeAlD
Nortriptyline—SLC6A4—head—thyroid cancer	5.35e-05	0.0291	CbGeAlD
Nortriptyline—CHRM1—head—thyroid cancer	5.33e-05	0.029	CbGeAlD
Nortriptyline—HRH1—trachea—thyroid cancer	4.83e-05	0.0263	CbGeAlD
Nortriptyline—CHRM3—head—thyroid cancer	4.77e-05	0.0259	CbGeAlD
Nortriptyline—HTR1A—head—thyroid cancer	4.75e-05	0.0258	CbGeAlD
Nortriptyline—SLC6A2—head—thyroid cancer	4.71e-05	0.0256	CbGeAlD
Nortriptyline—PTGS1—trachea—thyroid cancer	4.47e-05	0.0243	CbGeAlD
Nortriptyline—ORM1—lymph node—thyroid cancer	4.39e-05	0.0239	CbGeAlD
Nortriptyline—ADRA1A—head—thyroid cancer	4.38e-05	0.0238	CbGeAlD
Nortriptyline—DRD2—head—thyroid cancer	4.29e-05	0.0233	CbGeAlD
Nortriptyline—CYP1A2—thyroid gland—thyroid cancer	4.08e-05	0.0222	CbGeAlD
Nortriptyline—HTR2A—trachea—thyroid cancer	4.03e-05	0.0219	CbGeAlD
Nortriptyline—ALB—lymph node—thyroid cancer	3.85e-05	0.021	CbGeAlD
Nortriptyline—CYP2E1—thyroid gland—thyroid cancer	3.67e-05	0.02	CbGeAlD
Nortriptyline—PTGS1—thyroid gland—thyroid cancer	3.53e-05	0.0192	CbGeAlD
Nortriptyline—HRH1—head—thyroid cancer	3.39e-05	0.0184	CbGeAlD
Nortriptyline—SLC6A2—lymph node—thyroid cancer	3.3e-05	0.0179	CbGeAlD
Nortriptyline—CYP2E1—head—thyroid cancer	3.25e-05	0.0177	CbGeAlD
Nortriptyline—PTGS1—head—thyroid cancer	3.14e-05	0.0171	CbGeAlD
Nortriptyline—HTR2A—head—thyroid cancer	2.83e-05	0.0154	CbGeAlD
Nortriptyline—CYP2D6—head—thyroid cancer	2.58e-05	0.014	CbGeAlD
Nortriptyline—HRH1—lymph node—thyroid cancer	2.37e-05	0.0129	CbGeAlD
Nortriptyline—PTGS1—lymph node—thyroid cancer	2.2e-05	0.0119	CbGeAlD
Nortriptyline—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.71e-05	0.000191	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.7e-05	0.00019	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.69e-05	0.000189	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—KRAS—thyroid cancer	1.68e-05	0.000188	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	1.66e-05	0.000186	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—NRAS—thyroid cancer	1.66e-05	0.000186	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	1.65e-05	0.000185	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—KRAS—thyroid cancer	1.61e-05	0.00018	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TERT—thyroid cancer	1.6e-05	0.000179	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.59e-05	0.000178	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TERT—thyroid cancer	1.57e-05	0.000176	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TERT—thyroid cancer	1.57e-05	0.000176	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TERT—thyroid cancer	1.56e-05	0.000175	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—RXRA—thyroid cancer	1.56e-05	0.000175	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TERT—thyroid cancer	1.56e-05	0.000175	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TERT—thyroid cancer	1.54e-05	0.000173	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TERT—thyroid cancer	1.54e-05	0.000172	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.53e-05	0.000172	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HIF1A—thyroid cancer	1.53e-05	0.000171	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	1.53e-05	0.000171	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.52e-05	0.00017	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PPARG—thyroid cancer	1.52e-05	0.00017	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—HRAS—thyroid cancer	1.52e-05	0.00017	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	1.52e-05	0.00017	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.5e-05	0.000168	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HIF1A—thyroid cancer	1.5e-05	0.000168	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HIF1A—thyroid cancer	1.5e-05	0.000168	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TPR—thyroid cancer	1.49e-05	0.000167	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HIF1A—thyroid cancer	1.49e-05	0.000167	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HIF1A—thyroid cancer	1.48e-05	0.000165	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—AKT1—thyroid cancer	1.47e-05	0.000165	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	1.47e-05	0.000165	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.47e-05	0.000164	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	1.46e-05	0.000164	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.45e-05	0.000162	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.44e-05	0.000161	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—RXRA—thyroid cancer	1.44e-05	0.000161	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.43e-05	0.000161	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—HRAS—thyroid cancer	1.43e-05	0.00016	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—KRAS—thyroid cancer	1.43e-05	0.00016	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—RXRA—thyroid cancer	1.42e-05	0.000159	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CCND1—thyroid cancer	1.42e-05	0.000159	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—AKT1—thyroid cancer	1.39e-05	0.000156	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.39e-05	0.000155	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	1.37e-05	0.000154	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—PTEN—thyroid cancer	1.37e-05	0.000154	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—HRAS—thyroid cancer	1.37e-05	0.000153	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.36e-05	0.000152	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.35e-05	0.000151	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTGS2—thyroid cancer	1.35e-05	0.000151	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CCND1—thyroid cancer	1.34e-05	0.00015	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—AKT1—thyroid cancer	1.34e-05	0.00015	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—AKT1—thyroid cancer	1.33e-05	0.000149	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.33e-05	0.000148	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.32e-05	0.000148	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.32e-05	0.000148	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	1.32e-05	0.000148	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—NRAS—thyroid cancer	1.31e-05	0.000147	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.31e-05	0.000147	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	1.3e-05	0.000146	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.3e-05	0.000145	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—PTEN—thyroid cancer	1.29e-05	0.000145	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	1.29e-05	0.000144	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CCND1—thyroid cancer	1.28e-05	0.000144	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PPARG—thyroid cancer	1.28e-05	0.000143	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PPARG—thyroid cancer	1.28e-05	0.000143	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—thyroid cancer	1.27e-05	0.000142	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.27e-05	0.000142	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—AKT1—thyroid cancer	1.26e-05	0.000141	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	1.26e-05	0.000141	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	1.25e-05	0.00014	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.25e-05	0.000139	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.24e-05	0.000139	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PTEN—thyroid cancer	1.24e-05	0.000139	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—BRAF—thyroid cancer	1.24e-05	0.000139	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—BRAF—thyroid cancer	1.24e-05	0.000138	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NRAS—thyroid cancer	1.22e-05	0.000137	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—BRAF—thyroid cancer	1.22e-05	0.000137	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.22e-05	0.000137	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—RXRA—thyroid cancer	1.22e-05	0.000136	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—HRAS—thyroid cancer	1.21e-05	0.000136	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—AKT1—thyroid cancer	1.21e-05	0.000135	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	1.21e-05	0.000135	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000134	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.18e-05	0.000132	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTEN—thyroid cancer	1.17e-05	0.000131	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	1.17e-05	0.00013	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.16e-05	0.00013	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NRAS—thyroid cancer	1.16e-05	0.000129	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.14e-05	0.000128	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.14e-05	0.000127	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	1.14e-05	0.000127	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	1.13e-05	0.000127	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	1.13e-05	0.000127	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.12e-05	0.000126	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	1.12e-05	0.000125	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.12e-05	0.000125	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.12e-05	0.000125	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.12e-05	0.000125	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NRAS—thyroid cancer	1.11e-05	0.000124	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARG—thyroid cancer	1.1e-05	0.000123	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.09e-05	0.000122	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.09e-05	0.000122	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—thyroid cancer	1.07e-05	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	1.07e-05	0.00012	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—KRAS—thyroid cancer	1.05e-05	0.000118	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.05e-05	0.000118	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.05e-05	0.000117	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000116	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	1.04e-05	0.000116	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	1.04e-05	0.000116	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.02e-05	0.000114	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.01e-05	0.000113	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.01e-05	0.000113	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—thyroid cancer	1e-05	0.000112	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	1e-05	0.000112	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—KRAS—thyroid cancer	9.94e-06	0.000111	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	9.91e-06	0.000111	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARG—thyroid cancer	9.86e-06	0.00011	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	9.86e-06	0.00011	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—HRAS—thyroid cancer	9.86e-06	0.00011	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	9.7e-06	0.000109	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—HRAS—thyroid cancer	9.68e-06	0.000108	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	9.68e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	9.65e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	9.61e-06	0.000108	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	9.58e-06	0.000107	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	9.52e-06	0.000107	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—KRAS—thyroid cancer	9.52e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	9.5e-06	0.000106	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	9.44e-06	0.000106	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	9.43e-06	0.000106	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	9.41e-06	0.000105	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—RXRA—thyroid cancer	9.39e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	9.38e-06	0.000105	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—thyroid cancer	9.37e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	9.35e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	9.26e-06	0.000104	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCND1—thyroid cancer	9.24e-06	0.000103	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	9.23e-06	0.000103	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCND1—thyroid cancer	9.09e-06	0.000102	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCND1—thyroid cancer	9.07e-06	0.000102	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—thyroid cancer	9.07e-06	0.000102	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NRAS—thyroid cancer	9.06e-06	0.000101	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCND1—thyroid cancer	9.04e-06	0.000101	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NRAS—thyroid cancer	9.02e-06	0.000101	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCND1—thyroid cancer	9.02e-06	0.000101	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—thyroid cancer	8.99e-06	0.000101	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HRAS—thyroid cancer	8.96e-06	0.0001	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	8.95e-06	0.0001	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCND1—thyroid cancer	8.93e-06	9.99e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PTEN—thyroid cancer	8.92e-06	9.98e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	8.9e-06	9.97e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—thyroid cancer	8.84e-06	9.89e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PTEN—thyroid cancer	8.78e-06	9.82e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTEN—thyroid cancer	8.77e-06	9.82e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PTEN—thyroid cancer	8.76e-06	9.8e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTEN—thyroid cancer	8.75e-06	9.8e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PTEN—thyroid cancer	8.73e-06	9.77e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—thyroid cancer	8.7e-06	9.74e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PTEN—thyroid cancer	8.7e-06	9.74e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—thyroid cancer	8.64e-06	9.67e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	8.63e-06	9.66e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PTEN—thyroid cancer	8.62e-06	9.65e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	8.59e-06	9.62e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	8.56e-06	9.58e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—thyroid cancer	8.54e-06	9.56e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	8.52e-06	9.53e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	8.49e-06	9.5e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—thyroid cancer	8.46e-06	9.47e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—thyroid cancer	8.45e-06	9.46e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	8.41e-06	9.41e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	8.38e-06	9.38e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—thyroid cancer	8.09e-06	9.06e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRAS—thyroid cancer	7.96e-06	8.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—thyroid cancer	7.96e-06	8.91e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—thyroid cancer	7.91e-06	8.85e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRAS—thyroid cancer	7.83e-06	8.77e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRAS—thyroid cancer	7.81e-06	8.75e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—KRAS—thyroid cancer	7.8e-06	8.73e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRAS—thyroid cancer	7.79e-06	8.72e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRAS—thyroid cancer	7.76e-06	8.69e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—KRAS—thyroid cancer	7.76e-06	8.69e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—thyroid cancer	7.76e-06	8.68e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRAS—thyroid cancer	7.69e-06	8.61e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—thyroid cancer	7.68e-06	8.6e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	7.67e-06	8.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	7.61e-06	8.52e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTEN—thyroid cancer	7.54e-06	8.44e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—thyroid cancer	7.46e-06	8.35e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	7.43e-06	8.32e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—thyroid cancer	7.15e-06	8e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.14e-06	7.99e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—thyroid cancer	7.07e-06	7.92e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—thyroid cancer	6.93e-06	7.76e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—thyroid cancer	6.9e-06	7.72e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—KRAS—thyroid cancer	6.85e-06	7.67e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTEN—thyroid cancer	6.77e-06	7.57e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—thyroid cancer	6.76e-06	7.57e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—KRAS—thyroid cancer	6.74e-06	7.54e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—KRAS—thyroid cancer	6.73e-06	7.53e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	6.72e-06	7.52e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—KRAS—thyroid cancer	6.7e-06	7.5e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—KRAS—thyroid cancer	6.68e-06	7.48e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—thyroid cancer	6.63e-06	7.42e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—KRAS—thyroid cancer	6.62e-06	7.41e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—thyroid cancer	6.6e-06	7.39e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	6.6e-06	7.39e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—thyroid cancer	6.6e-06	7.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	6.32e-06	7.07e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTEN—thyroid cancer	6.22e-06	6.97e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTEN—thyroid cancer	6.17e-06	6.91e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—thyroid cancer	6.09e-06	6.81e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—thyroid cancer	6.04e-06	6.77e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—thyroid cancer	6e-06	6.71e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—thyroid cancer	5.99e-06	6.71e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—thyroid cancer	5.98e-06	6.69e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—thyroid cancer	5.96e-06	6.67e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—thyroid cancer	5.94e-06	6.65e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—thyroid cancer	5.93e-06	6.64e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—thyroid cancer	5.88e-06	6.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—thyroid cancer	5.87e-06	6.57e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—thyroid cancer	5.86e-06	6.55e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—thyroid cancer	5.82e-06	6.52e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—thyroid cancer	5.82e-06	6.52e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—thyroid cancer	5.73e-06	6.41e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—thyroid cancer	5.72e-06	6.4e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—thyroid cancer	5.7e-06	6.38e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—thyroid cancer	5.68e-06	6.36e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—thyroid cancer	5.62e-06	6.3e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	5.61e-06	6.28e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	5.58e-06	6.24e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTEN—thyroid cancer	5.27e-06	5.9e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—thyroid cancer	5.14e-06	5.75e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—thyroid cancer	5.06e-06	5.66e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—thyroid cancer	5.05e-06	5.66e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—thyroid cancer	5.05e-06	5.65e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—thyroid cancer	5.04e-06	5.65e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—thyroid cancer	5.03e-06	5.63e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—thyroid cancer	5.02e-06	5.61e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—thyroid cancer	4.97e-06	5.56e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	4.95e-06	5.54e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.67e-06	5.22e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—thyroid cancer	4.34e-06	4.86e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTEN—thyroid cancer	4.07e-06	4.55e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—thyroid cancer	3.9e-06	4.36e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—thyroid cancer	3.59e-06	4.01e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—thyroid cancer	3.56e-06	3.98e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—thyroid cancer	3.04e-06	3.4e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—thyroid cancer	2.34e-06	2.62e-05	CbGpPWpGaD
